PulseAugur
EN
LIVE 20:48:18
ENTITY Respiratory Syncytial Virus mRNA vaccine

Respiratory Syncytial Virus mRNA vaccine

PulseAugur coverage of Respiratory Syncytial Virus mRNA vaccine — every cluster mentioning Respiratory Syncytial Virus mRNA vaccine across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TIMELINE
  1. 2026-05-29 research_milestone Naimi Xin's RSV mRNA vaccine has officially begun Phase II clinical trials. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. TOOL · CL_59516 ·

    Kanghua Bio subsidiary begins Phase II trials for RSV mRNA vaccine

    Kanghua Bio announced that its subsidiary, Naimi Xin, has initiated Phase II clinical trials for its self-developed lyophilized respiratory syncytial virus (RSV) mRNA vaccine. This development marks a significant step i…